Position in NTRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$548,057
+$313,011 QoQ
Shares Held
2,019
+96.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#517
of 844 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ELEVATUS WELATH MANAGEMENT holds $3,470,975 across 6 Diagnostics & Research names. NTRA ranks #3 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,352 | $1,179,198 | |
| 2 | DHR |
Danaher Corp /De/
|
3,246 | $618,298 | |
| 3 | NTRA |
Natera, Inc.
This page
|
2,019 | $548,057 | |
| 4 | A |
Agilent Technologies, Inc.
|
3,795 | $504,089 | |
| 5 | RVTY |
Revvity, Inc.
|
3,531 | $392,859 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
434 | $228,474 |
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $548,057 | 2,019 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $235,046 | 1,026 | Shares | Sole | 2026-01-14 | |
| No filing history on record for this holder in this stock. | ||||||